Bernd Meibohm
Impact in
- Pharmacology top 0.5%
- Pharmacogenetics and Drug Metabolism
- Antibiotics Pharmacokinetics and Efficacy
- Transplantation top 2%
Papers in
- Pharmacology 18
- Antibiotics Pharmacokinetics and Efficacy 24
- Pharmacogenetics and Drug Metabolism 17
-
- Pharmaceutical studies and practices 26
- Co-authors
- Hartmut DerendorfJosiah RymanNathanael L. DirksLei DiaoStephanie LäerGünther HochhausJeffrey S. BarrettNarendra Chirmule
- Journals
- The Journal of Clinical Pharmacology (20 papers)The AAPS Journal (12 papers)Clinical Pharmacokinetics (7 papers)PLoS ONE (5 papers)Tuberculosis (5 papers)
- Partner nations
- United StatesGermanyChina
In The Last Decade
Bernd Meibohm
163 papers receiving 7.2k citations
Hit Papers
Peers
Comparison fields: 5 of 158
- Pharmacology 719
- Transplantation 197
- Pediatrics, Perinatology and Child Health 1.1k
- Pharmacology 886
- Immunology 1.1k
Countries citing papers authored by Bernd Meibohm
This map shows the geographic impact of Bernd Meibohm's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernd Meibohm with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernd Meibohm more than expected).
Fields of papers citing papers by Bernd Meibohm
This network shows the impact of papers produced by Bernd Meibohm. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernd Meibohm. The network helps show where Bernd Meibohm may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bernd Meibohm, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 2 | |
| 5 | 2024 | 4 | |
| 6 | 2024 | 4 | |
| 7 | 2024 | 1 | |
| 8 | 2023 | 7 | |
| 9 | 2022 | 12 | |
| 10 | 2021 | 30 | |
| 11 | 2020 | 11 | |
| 12 | 2019 | 35 | |
| 13 | 2015 | 25 | |
| 14 | 2015 | 7 | |
| 15 | 2014 | 29 | |
| 16 | 2011 | 3 | |
| 17 | 2009 | 28 | |
| 18 | 2008 | 55 | |
| 19 | 2007 | 84 | |
| 20 | 2005 | 137 |
About Bernd Meibohm
Bernd Meibohm is a scholar working on Pharmacology, Pharmacology, Pediatrics, Perinatology and Child Health, Infectious Diseases and Immunology, having authored 170 papers that have together received 7.5k indexed citations. Recurring topics across this work include Pharmaceutical studies and practices (26 papers), Antibiotics Pharmacokinetics and Efficacy (24 papers), Monoclonal and Polyclonal Antibodies Research (21 papers), Tuberculosis Research and Epidemiology (19 papers), Biosimilars and Bioanalytical Methods (18 papers), Pharmacogenetics and Drug Metabolism (17 papers), Cancer therapeutics and mechanisms (17 papers) and Drug Transport and Resistance Mechanisms (14 papers). The work is most often cited by research in Pharmacology (719 citations), Transplantation (197 citations), Pediatrics, Perinatology and Child Health (1.1k citations), Pharmacology (886 citations) and Immunology (1.1k citations). Bernd Meibohm has collaborated with scholars based in United States, Germany and China. Frequent co-authors include Hartmut Derendorf, Josiah Ryman, Nathanael L. Dirks, Hartmut Derendorf, Lei Diao, Stephanie Läer, Günther Hochhaus, Jeffrey S. Barrett, Narendra Chirmule and Vibha Jawa. Their work appears in journals such as The Journal of Clinical Pharmacology, The AAPS Journal, Clinical Pharmacokinetics, PLoS ONE and Tuberculosis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.